ArticlePharmaceutics2025

New and Effective Inhibitor of Class I HDACs, Eimbinostat, Reduces the Growth of Hematologic Cancer Cells and Triggers Apoptosis.

Pavel Spirin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.